P&G Backs Proposed SPF Cap For Sunscreens, In Break From Rivals

Procter & Gamble files comments in support of FDA’s proposed 50+ SPF cap for OTC sunscreens, maintaining that high-SPF products do not provide a significant incremental protective benefit. P&G also cites harmonization with international regulatory frameworks in comments to FDA.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America